Exit Site Management
Conventional Exit Site Management (ESMTM) practices typically consist of hygienic handling of the catheter during dialysis sessions and the labour intensive use of antimicrobial dressings between dialysis sessions.
Marvao Medical’s alternative approach to ESMTM is to provide a catheter that enables the skin to heal into the device where it exits the patient, thus establishing a natural biological seal. In essence, once healed, there would be “no exit site”. Hence NexSite™ was developed.
Selected Peer Reviewed Publications – Exit Site Management
2. “Randomized, controlled trial of topical exit site application of honey (medihoney) vrs Mupirocin for the prevention of catheter related infections in HD patients”
Journal of American Society of Nephrology 16: 1456 – 1462 (2005)
David Johnson et al
Chris Davey – CEO, Co-Founder
Mr. Davey has more than 25 years experience in developing and commercializing medical device technology, primarily at Boston Scientific (13 years). He holds an MBA from Northeastern University (Boston MA) and relocated to Ireland in 2005 to co-found Marvao Medical Devices. Mr. Davey is a named inventor on 14 patents and 4 patent applications.
Eamonn Hobbs – Chairman
Mr. Hobbs has more than 30 years of experience developing and commercializing medical device technology. Mr Hobbs is Co-Founder and former CEO of Angiodynamics. Mr Hobbs is currently CEO of Anteres Pharmaceuticals, currently serves on several Boards across the industry, is a past Chairman of the Board for the Medical Device Manufactures association (MDM) and has previously served as a Board member for the Society of Interventional Radiology foundation (SIR).
Chris Davey – Co-Founder
Mr. Davey has more than 25 years of experience developing and commercializing medical device technology, primarily at Boston Scientific (13 years). He holds an MBA from Northeastern University (Boston MA) and relocated to Ireland in 2005 to co-found Marvao Medical. Mr. Davey is a named inventor on 14 patents and 4 patent applications.
Mark Saab – Co-Founder
Mr. Saab is President of Advanced Polymers, a successful medical device component manufacturer he co-founded in 1989 with his wife, Elisia, in Salem, New Hampshire. Mr. Saab has more than 30 years of experience in the medical device industry, and holds over 30 patents. Mr. Saab has also been a co-founder/investor in several medical component start-up companies. In 2010, Advanced Polymers merged with The MedTech Group, and is now part of Vention Medical.
Mr. Burns has more than 30 years of experience at senior management level within the life sciences industry. In 1978 he founded Birex Pharmaceuticals, which is now Helsinn Birex. He is a past president of the Federation of Irish Chemical Industries and former Chairman of the Irish Marketing Institute.
Mr. McEnroe is Managing Director of the Irish division of US based Harmac Medical Products. He started the division in 1998 and has grown the business to its current level, which employs almost 200 people. Mr McEnroe is a past President of IMDA, and also sits on the board of the parent company, based in Buffalo, NY.
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.
Marvao Medical’s investors include, Enterprise Ireland, the founders and other private investors.
Marvao Medical’s manufacturing partner for NexSite™ technology is Harmac Medical. For more information on Harmac please visit www.harmac.com